[1]
P. S., Ajay Kumar, Jyotiprakash Bhanja, Rahaman Shaik, Akash Limba Kawale, and Roshan Kumar, “A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer”, Int. j. res. appl. sci. biotechnol., vol. 9, no. 3, pp. 201–209, Jun. 2022.